Swiss Consumer Finance Stock News

Amid renewed worries about inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have experienced a downturn, with the pan-European STOXX Europe 600 Index ending 2.21% lower. Despite this challenging environment, opportunities may exist in stocks that are priced below their estimated value, offering potential for investors who focus on fundamental strengths such as solid business models and sustainable growth prospects.

There wouldn't be many who think Siegfried Holding AG's ( VTX:SFZN ) price-to-earnings (or "P/E") ratio of 20.5x is...

Mobimo Holding AG's ( VTX:MOBN ) price-to-earnings (or "P/E") ratio of 15.7x might make it look like a buy right now...

Sulzer (VTX:SUN) has had a rough three months with its share price down 8.9%. But if you pay close attention, you might...

Medacta Group's (VTX:MOVE) stock up by 6.5% over the past three months. Given its impressive performance, we decided to...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

medmix AG's ( VTX:MEDX ) price-to-sales (or "P/S") ratio of 0.8x may look like a very appealing investment opportunity...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Nestlé (SWX:NESN) stock price has shown some movement over the past month, leaving investors considering how recent performance might fit into their portfolios. While there has not been a specific event driving the action, the company’s fundamentals remain in focus. See our latest analysis for Nestlé. While Nestlé’s share price has edged higher by 7.8% over the past 90 days, the 1-year total shareholder return of 9.2% hints at steady, if unspectacular, gains. Momentum is gathering pace lately...

PolyPeptide Group AG's ( VTX:PPGN ) price-to-sales (or "P/S") ratio of 2.4x might make it look like a buy right now...

UBS Group (SWX:UBSG) shares have edged down about 2% over the past month. Investors may be reassessing the bank's performance and keeping an eye on valuation, as the stock trades slightly below its recent highs. See our latest analysis for UBS Group. While UBS Group has pulled back slightly over the past month, the longer view tells a more positive story. The stock's 1-year total shareholder return stands at 8.4%, and over the past five years, investors have seen total returns of more than...

One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...

With its stock down 16% over the past three months, it is easy to disregard BELIMO Holding (VTX:BEAN). However, stock...

PSP Swiss Property AG recently released third quarter and nine-month earnings, reporting sales of CHF 87.48 million for the quarter and CHF 261.39 million over the nine months ended September 30, 2025, with respective net incomes of CHF 65.14 million and CHF 259.48 million. While quarterly net income declined compared to the previous year, the company achieved a higher cumulative net income over nine months despite stable sales, highlighting nuanced changes in operational efficiency and cost...

On November 20, 2025, Avolta AG announced it had secured two 10-year contracts at Washington Dulles International Airport, expanding its presence with new Hudson retail and food locations, locally themed stores, and enhanced digital engagement features. This move reflects Avolta’s commitment to integrating local businesses and innovative retail formats in North America, while supporting its wider global expansion and traveler loyalty initiatives. We'll now explore how Avolta's long-term...

Roche Holding (SWX:ROG) has seen its stock climb around 16% over the past month, reflecting investor interest in the company’s recent financial performance and steady outlook. The market appears focused on Roche’s growth trends and valuation. See our latest analysis for Roche Holding. Roche Holding has picked up serious momentum, with a 16.2% 1-month share price return and a 28.2% total shareholder return over the last year. This surge reflects renewed optimism in the company's outlook and...

SHL Telemedicine Ltd. ( VTX:SHLTN ) shareholders are no doubt pleased to see that the share price has bounced 31% in...

Montana Aerospace AG ( VTX:AERO ) shares have had a horrible month, losing 25% after a relatively good period...

Novartis recently announced a $23 billion expansion of its US manufacturing footprint, including new state-of-the-art facilities in North Carolina and a focus on end-to-end drug production for the American market. The company simultaneously rolled forward its mid-term sales guidance to a 5-6% compound annual growth rate for 2025-2030, underlining strong operational confidence and ambitious growth expectations. We'll explore how Novartis's US manufacturing investment and upgraded guidance...

Sonova Holding (SWX:SOON) drew attention after posting half-year results with lower sales and net income. The company still reaffirmed its full-year sales growth outlook and revealed a revamp of its organizational structure. See our latest analysis for Sonova Holding. Sonova Holding’s recent half-year earnings, organizational shake-up, and confirmed sales guidance have all grabbed investor attention, but the momentum has been anything but positive. Its share price has tumbled 14.6% over the...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Earlier this week, UBS upgraded VAT Group AG from Neutral to Buy, highlighting anticipated positive order momentum in early 2026 driven by expected growth in AI data centers and rising semiconductor memory chip prices. A key insight from UBS’s outlook is that VAT Group’s leading role in vacuum valve technology, with an estimated 70% global market share, positions it to benefit as semiconductor industry capital spending ramps up in 2026–2027. We'll examine how expectations of increased...